WO2024252420 - TRIPLE RELEASE TABLET-IN-TABLET FORMULATION
National phase entry is expected:
Publication Number
WO/2024/252420
Publication Date
12.12.2024
International Application No.
PCT/IN2024/050696
International Filing Date
07.06.2024
Title **
[English]
TRIPLE RELEASE TABLET-IN-TABLET FORMULATION
[French]
FORMULATION DU TYPE COMPRIMÉ DANS COMPRIMÉ À LIBÉRATION TRIPLE
Applicants **
AKUMS DRUGS & PHARMACEUTICALS LIMITED
304, Mohan Place, LSC, Block-C, Saraswati Vihar
Delhi 110034, IN
Inventors
JAIN, Sanjeev
304, Mohan Place, LSC, Block-C, Saraswati Vihar
Delhi 110034, IN
CHAUDHARY, Arun
304, Mohan Place, LSC, Block-C, Saraswati Vihar
Delhi 110034, IN
Priority Data
202311039471
08.06.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1071 | |
| EPO | Filing, Examination | 6668 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 11613 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to tablet in tablet formulation comprising an inner core tablet having Proton pump inhibitor as an active ingredient and outer shell having Prokinetic agents as an active ingredient wherein outer shell have a bi-layer structure of immediate release and sustained release comprising Prokinetic agent. The inner core tablet of present invention is enteric coated with pH dependent polymer to avoid release of active ingredient in stomach and provide delayed release effects.[French]
La présente invention concerne une formulation du type comprimé dans comprimé comprenant un comprimé à noyau interne ayant un inhibiteur de pompe à protons en tant que principe actif et une enveloppe externe ayant des agents pro-cinétiques en tant que principe actif, l'enveloppe externe ayant une structure bicouche de libération immédiate et de libération prolongée comprenant un agent pro-cinétique. Le comprimé à noyau interne de la présente invention est revêtu d'un polymère dépendant du pH pour éviter la libération d'un principe actif dans l'estomac et fournir des effets de libération retardée.